Polycythemia in a Pediatric Patient with Chronic Kidney Disease: Overuse of Erythropoetin During COVID-19 Isolation

Basit Öğe Kaydı
dc.contributor.authorKandur, Yaşar
dc.contributor.authorAlpcan, Ayşegül
dc.contributor.authorYozgat, Mehmet
dc.contributor.authorTursun, Serkan
dc.date.accessioned2025-01-21T16:13:41Z
dc.date.available2025-01-21T16:13:41Z
dc.date.issued2021
dc.departmentKırıkkale Üniversitesi
dc.description.abstractWe describe a case of a patient with Chronic Kidney Disease who developed polycythemia due to Erythropoiesis Stimulating Agents overuse during COVID-19 isolation. A 12-year-old male had not been able to attend routine controls since had been in isolation for 4 months after the COVID-19 outbreak. He had continued to take Erythropoiesis- Stimulating Agents during that period at the starting dose of 150 U/kg/week. He had been on peritoneal dialysis in the last year because of end-stage renal failure. Laboratory investigation revealed a hemoglobin (Hb) level of 20.8 g/dl, hematocrit level of 66%, creatinine level of 6.5 mgr/dl. He underwent daily phlebotomy sessions (10cc/kg/session). During this period aspirin was also started (5mg/kg). After 5 sessions his Hb level decreased to 14 gr/dl and hematocrit to 40%. Pediatric nephrologist should be aware that there is a potential risk of polycythemia with Erythropoiesis Stimulating Agents when Hb level is not appropriately followed on a routine basis.
dc.identifier.doi10.12956/tchd.833625
dc.identifier.endpage436
dc.identifier.issn1307-4490
dc.identifier.issn2148-3566
dc.identifier.issue5
dc.identifier.startpage434
dc.identifier.trdizinid1194460
dc.identifier.urihttps://doi.org/10.12956/tchd.833625
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1194460
dc.identifier.urihttps://hdl.handle.net/20.500.12587/21983
dc.identifier.volume15
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofTürkiye Çocuk Hastalıkları Dergisi
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241229
dc.subjectKadın Hastalıkları ve Doğum
dc.subjectÜroloji ve Nefroloji
dc.subjectHematoloji
dc.subjectSağlık Bilimleri ve Hizmetleri
dc.subjectPediatri
dc.titlePolycythemia in a Pediatric Patient with Chronic Kidney Disease: Overuse of Erythropoetin During COVID-19 Isolation
dc.typeArticle

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu